GlassScriptPhysician profile
Meghan Mccaskey
NPI 1891323218
$5,852.95
in general payments reported to CMS, 2019-2025
12 companies · $3,446 in 2025
The $3,446 reported for 2025 was more than what 97% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $20.16 · 2022: $380 · 2023: $586 · 2024: $1,420 · 2025: $3,446.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $2,500 · Food and Beverage: $2,314 · Travel and Lodging: $638.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $2,500.00 |
| Food and Beverage | $2,314.16 |
| Travel and Lodging | $638.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $2,662.31 | 2025 | Bioinductive Implant With Arthroscopic Delivery System - Medium, Collagenase Santyl, Oasis |
| Stryker Corporation | $1,252.82 | 2022-2024 | Pro, Gamma, T2 |
| Zimmer Biomet Holdings, INC. | $518.20 | 2024-2025 | Affixus, Gel-One Cross-Linked Hyaluronate, Persona |
| Medtronic, INC. | $403.37 | 2021-2023 | Plasmablade(Tm) |
| Coastal Medical Technologies LLC | $345.88 | 2023-2025 | |
| Heron Therapeutics, INC. | $124.95 | 2024 | Zynrelef |
| Mvp Orthopedics INC | $123.82 | 2022-2023 | |
| Polynovo North America LLC | $123.56 | 2025 | Novosorb Btm |
| Vericel Corporation | $120.59 | 2024 | Maci |
| Kci USA, INC. | $85.70 | 2023 | Prevena |
| Medinc of Texas | $48.11 | 2025 | |
| Integra Lifesciences Corporation | $43.64 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Meghan Mccaskey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.